Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach

Allyson J. Ocean, Paul Christos, Joseph A. Sparano, Manish A. Shah, Rhonda K. Yantiss, Jonathan Cheng, Juan Lin, Michael Papetti, Dan Matulich, Felice Schnoll-Sussman, Christen Besanceney-Webler, Jenny Xiang, Maureen Ward, Kaili Temple Dilts, Roger Keresztes, Shannon Holloway, Eric X. Chen, John J. Wright, Maureen E. Lane

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach'. Together they form a unique fingerprint.

Medicine & Life Sciences